These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 32962495)

  • 1. Possible effect of epinephrine in minimizing COVID-19 severity: a review.
    Derakhshan M; Ansarian HR; Ghomshei M
    J Int Med Res; 2020 Sep; 48(9):300060520958594. PubMed ID: 32962495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 3. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
    Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
    Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can melatonin reduce the severity of COVID-19 pandemic?
    Shneider A; Kudriavtsev A; Vakhrusheva A
    Int Rev Immunol; 2020; 39(4):153-162. PubMed ID: 32347747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
    Xie L; Wu Q; Lin Q; Liu X; Lin W; Hao S; Hu W; Xiang G; Lu H; Li S
    Ther Adv Respir Dis; 2020; 14():1753466620942129. PubMed ID: 32684101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 9. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of CD8 marker on T-cells in COVID-19 patients.
    Ganji A; Farahani I; Khansarinejad B; Ghazavi A; Mosayebi G
    Blood Cells Mol Dis; 2020 Jul; 83():102437. PubMed ID: 32325421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status could be associated with severity in COVID-19 patients.
    Liu C; Yang J; Wang W; Mi Y; Tang Y; Zheng P
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):13-16. PubMed ID: 32965348
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.
    Liaudet L; Szabo C
    Crit Care; 2020 Jun; 24(1):318. PubMed ID: 32513242
    [No Abstract]   [Full Text] [Related]  

  • 18. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom.
    Liu Z; Magal P; Webb G
    J Theor Biol; 2021 Jan; 509():110501. PubMed ID: 32980371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.